Wednesday August 11, 2021, San Diego Metro Magazine

0
San Diego State University researchers
secure funding of $ 141 million for 2020-2021

Researchers at San Diego State University have secured $ 140.6 million in grants for 2020-2021, keeping the institution’s research business in the midst of a global pandemic.

Nearly 320 principal investigators received 723 awards, including strong support in crucial areas such as increasing adoption of the COVID-19 vaccine, developing better batteries for electric cars, reducing disease among Hispanics , the fight against climate change and the improvement of employment opportunities for people with disabilities.

Many research leaders have also played a dual role of mentor, and hundreds of students have participated in high-impact research projects over the past year.

More than 570 graduate students and 380 undergraduates participated in on-campus research in 2020-2021, and the Research and Innovation Division (DRI) has financially supported more than 170 student researchers with grants. About 300 students participated in the 2021 Student Research Symposium.

“It has been a great year for a wide range of crucial research,” said Hala Madanat, Acting Vice President for Research and Innovation. “The SDSU professors were ambitious in their efforts. From climate change to racial justice to artificial intelligence, their work has addressed issues critical to our future. “

PHOTO: Undergraduate Kaylin Sabado performs an energy efficiency assessment with the SDSU Industrial Assessment Center.

Read more…


Scripps Whittier Diabetes Institute receives
$ 3.1 million grant to study blood glucose monitoring

The National Institutes of Health awarded a grant of $ 3.1 million to the Scripps Whittier Diabetes Institute to study the use of wireless continuous blood glucose monitoring (CGM) devices in hospitalized patients with type 2 diabetes in the hope of better controlling their blood sugar upon admission.

The new study will build on previous research conducted by Scripps Whittier and the further use of CGM devices in diabetic patients at Scripps Health hospitals during the COVID-19 pandemic. At the start of the public health crisis, the Food and Drug Administration paved the way for hospitals to use the devices to reduce the number of times a nurse has to visit a patient’s room for finger pricks. more conventional. Without CGM, nurses typically enter a patient’s room four to six times a day to check blood sugar.


Steve Kietz appointed Managing Director
head of Reliant Funding in San Diego
Steve kietz

Reliant Funding, a small business finance company, has appointed Steve Kietz as Managing Director. Kietz was previously the company’s marketing director. The industry veteran will guide Reliant Funding on its mission to continue to provide personalized, world-class financing solutions to US small businesses.

As Chief Marketing Officer, Kietz has been instrumental in expanding Reliant Funding’s marketing, risk and technology initiatives. He is a seasoned financial services professional with over 30 years of experience leading successful teams and is widely recognized as an industry leader in building strategic partnerships.

Prior to joining Reliant, Kietz served as Chairman of Inte Q, was Founder and CEO of Mobile Money Ventures (which was acquired by Intuit), and held senior positions at Citi and JP Morgan, including Chairman of Citibank Direct. Outside of the profession, Kietz has volunteered as vice-president of the Family Dysautonomia Foundation for over 30 years.


SpaceLink and Blue Marble Communications
work on the development of advanced optical terminals

Space link, a company that is building an information highway for the space economy, has announced the formation of a strategic partnership with the San Diego-based company Blue marble communications accelerate the development of advanced optical terminals.

Blue Marble is a supplier of high-performance, high-speed data, RF and optical communications components.

The terms of the agreement between the two companies, valued at more than $ 10 million, include technological development and the purchase of terminals for inter-satellite links compatible with the Space development agency standards (SDA). A diverse range of terminals for inter-satellite optical links helps SpaceLink manage risk and provide options to its customers.


HCAP Partners announces new
investment in Myndshft

HCAP Partners, a San Diego-based private equity firm and nationally recognized impact investor, announced its investment in Myndshft, a leading provider of real-time medical benefits monitoring and electronic prior authorization technologies. Terms of the investment were not disclosed.

Based in Mesa, Arizona, Myndshft develops real-time medical benefit verification and electronic pre-authorization software solutions for payers and providers.

“Improving access to care is a key investment theme for us at HCAP,” said Hope Mago, partner at HCAP Partners. “We have been impressed with Myndshft’s approach of leveraging artificial intelligence and blockchain technology to solve an important problem in healthcare. We look forward to working with the Myndshft team during this time of significant business growth. “


Sydnexis secures $ 45 million Series B funding
led by Visionary Ventures and Blue Stem Capital

Sydnexis Inc., a clinical-stage biopharmaceutical company with a proprietary formulation of low-dose atropine for the treatment of progressive myopia, announced the completion of a $ 45 million Series B funding led by Visionary Ventures, Blue Stem Capital and SC Master Fund, with participation from existing investors RA Capital Management, Longitude Capital and Medicxi.

The funding will be used to fund Sydnexis lead candidate, SYD-101, until the completion of the fully recruited, pivotal phase 3 STAAR study for the treatment of progressive myopia in children.

The Sydnexis STAAR study is the world’s largest pediatric myopia study to investigate the use of low-dose atropine to delay progressive myopia.


LifeWave of San Diego offers relief
to the victims of the German floods

LifeWave, a San Diego-based healthcare technology company, has volunteered to provide care packages for victims of the deadly floods that hit western Germany in July. Flash floods destroyed homes, washed away roads, smashed dams and quickly pushed rivers to their shores, burying entire towns under heavy blankets of mud. 225 people died.

“When we got the call, we were quick to lend a hand to help those battling the unprecedented floods and fallout,” said Jim Caldwell, Chief Marketing Officer of LifeWave. “Our LifeWave team has shown solidarity and support to our German friends, their families and first responders with shipments of LifeWave products to help them tackle stress, insomnia and general discomfort.

LifeWave manufactures ultra-thin, non-transdermal patches that harness light frequencies to stimulate points in the skin to promote energy, sleep, relaxation, and minor pain relief. The patches are portable, painless, effective and easy to use.


Potential COVID-19 drug found among tapeworm drugs

A group of drugs long prescribed to treat tapeworm have inspired a compound that shows two-fold efficacy against COVID-19 in laboratory studies, according to a new publication appearing online in the journal Infectious disease of ACS.

The compound, which is part of a class of molecules called salicylanilides, was designed in the laboratory of Professor Kim Janda, chemistry professor Ely R. Callaway Jr. and director of the Worm Institute for Research and Medicine at Scripps Research in La Jolla.

“We have known for 10 or 15 years that salicylanilides work against certain viruses,” explains Janda. “However, they tend to be restricted to the gut and can have toxicity issues.”

Janda’s compound overcomes both problems, in mouse and cell tests, acting as both an antiviral and anti-inflammatory compound, with properties that bode well for its use in pill form.


Read more…

Southwestern College Student Journal
named one of the 100 best American publications

Southwestern College’s student newspaper The Sun has been named one of America’s Top 100 Publications by the Associated Collegiate Press (ACP). The prestigious designation was announced by ACP, the oldest student journalism organization in North America, as part of a celebration of the 100th anniversary of the CAP.

The Sun has been recognized alongside esteemed student publications from universities such as Northwestern, Missouri, UCLA, and USC. Since its inception, The Sun has quickly gained recognition for its high-quality coverage, securing its first Pacemaker Award from the CAP for Distinguished Student Journalism early in its existence. The Sun has consistently launched graduates into successful, high-profile journalism careers, including nearly every San Diego news outlet and national media like Politico.


Source link

Leave A Reply

Your email address will not be published.